Healthcare Analysts, along with Drs. Solomon and Appleby, discuss the upcoming Clinical Trials in Alzheimer’s Disease (CTAD) Meeting and Eisai and Biogen’s Lecanemab in the second of two Analyst/Industry conference calls to be held on December 2.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ESALY: